title: Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan.
authors.forename: K
authors.initials: K
authors.lastname: Miyazawa
authors.forename: J
authors.initials: J
authors.lastname: Nishimaki
authors.forename: K
authors.initials: K
authors.lastname: Ohyashiki
authors.forename: S
authors.initials: S
authors.lastname: Enomoto
authors.forename: S
authors.initials: S
authors.lastname: Kuriya
authors.forename: R
authors.initials: R
authors.lastname: Fukuda
authors.forename: T
authors.initials: T
authors.lastname: Hotta
authors.forename: M
authors.initials: M
authors.lastname: Teramura
authors.forename: H
authors.initials: H
authors.lastname: Mizoguchi
authors.forename: T
authors.initials: T
authors.lastname: Uchiyama
authors.forename: M
authors.initials: M
authors.lastname: Omine
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D010865:Pilot Projects; D014812:Vitamin K / Q000031:analogs & derivatives* / Q000627:therapeutic use; D024482:Vitamin K 2 / Q000031:analogs & derivatives
chemical_list: D024482:Vitamin K 2; D014812:Vitamin K; C030814:menatetrenone